Intellia Therapeutics (NTLA) Other Gross PP&E Adjustments (2016 - 2025)
Intellia Therapeutics (NTLA) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$55.7 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 68.53% to -$55.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$55.7 million through Dec 2025, up 68.53% year-over-year, with the annual reading at -$55.7 million for FY2025, 68.53% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$55.7 million at Intellia Therapeutics, up from -$120.6 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$5.5 million in Q2 2021, with the low at -$177.0 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$92.7 million, with a median of -$103.6 million recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 78.28% in 2021, then crashed 1297.48% in 2022.
- Over 5 years, Other Gross PP&E Adjustments stood at -$39.8 million in 2021, then tumbled by 137.15% to -$94.5 million in 2022, then rose by 22.55% to -$73.2 million in 2023, then tumbled by 141.99% to -$177.0 million in 2024, then soared by 68.53% to -$55.7 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$55.7 million, -$120.6 million, and -$131.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.